| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.342 | 86.746 | 103.241 | 128.702 | 134.544 | 95.483 | 104.249 | 146.318 | 143.448 | 126.428 |
| Total Income - EUR | 40.342 | 86.746 | 103.241 | 128.702 | 134.545 | 100.445 | 104.655 | 146.321 | 143.455 | 127.413 |
| Total Expenses - EUR | 30.396 | 58.390 | 60.948 | 75.026 | 76.444 | 63.579 | 68.829 | 75.854 | 88.115 | 110.141 |
| Gross Profit/Loss - EUR | 9.946 | 28.355 | 42.294 | 53.677 | 58.101 | 36.866 | 35.826 | 70.467 | 55.340 | 17.273 |
| Net Profit/Loss - EUR | 8.736 | 27.488 | 41.260 | 52.390 | 56.755 | 35.895 | 34.780 | 69.004 | 53.906 | 14.972 |
| Employees | 3 | 4 | 4 | 5 | 5 | 5 | 6 | 5 | 6 | 5 |
Check the financial reports for the company - 3G Rx Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.180 | 20.258 | 33.813 | 29.344 | 28.382 | 23.773 | 19.895 | 15.975 | 11.956 | 2.611 |
| Current Assets | 809 | 21.596 | 10.248 | 26.311 | 31.562 | 16.370 | 17.787 | 57.453 | 47.592 | 16.942 |
| Inventories | 88 | 3.248 | 90 | 88 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 621 | 630 | 1.220 | 1.226 | 1.972 | 1.434 | 32.449 | 39.650 | 0 |
| Cash | 721 | 17.727 | 9.529 | 25.003 | 30.337 | 14.399 | 16.353 | 25.004 | 7.943 | 16.942 |
| Shareholders Funds | 12.680 | 40.039 | 41.465 | 52.591 | 56.952 | 36.088 | 34.969 | 69.194 | 54.095 | 15.160 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 1.308 | 1.816 | 2.597 | 3.064 | 2.992 | 4.055 | 2.714 | 4.234 | 5.454 | 4.394 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - 3G Rx Srl